Allegro Diagnostics Announces BronchoGen™ Genomic Test for Improved Diagnosis of Lung Cancer Successfully Achieves Clinical Validation
3/12/2013 9:25:54 AM
More...
|
Allegro Diagnostics Presents Positive AEGIS I Trial Results of BronchoGen™ Genomic Test to Improve Diagnosis of Lung Cancer at Annual CHEST Meeting
10/23/2012 9:16:39 AM
More...
|
Allegro Diagnostics to Participate in Upcoming Conferences in September
8/30/2012 10:08:04 AM
More...
|
Allegro Diagnostics to Present Clinical Trial Results of BronchoGen™ Genomic Test to Improve Diagnosis of Lung Cancer in Late-Breaking Abstract Session at CHEST 2012
8/27/2012 9:54:32 AM
More...
|
Allegro Diagnostics Completes Patient Enrollment in 1,320-Patient AEGIS II Study of BronchoGen™ Genomic Test for Improved Detection of Lung Cancer
7/24/2012 9:56:18 AM
More...
|
Allegro Diagnostics Appoints Clinical and Scientific Advisory Board Comprised of Experts in Pulmonology, Lung Cancer and Molecular Diagnostics
6/26/2012 12:49:02 PM
More...
|
Allegro Diagnostics to Present at 2012 Biotechnology Industry Organization (BIO) International Convention
6/6/2012 9:58:45 AM
More...
|
Allegro Diagnostics Promotes Duncan Whitney, Ph.D, to Senior Vice President, Research and Development
2/14/2012 10:22:18 AM
More...
|
Allegro Diagnostics Closes on $5.4M Financing
7/7/2011 10:20:30 AM
More...
|
Allegro Diagnostics Enters License Agreement for Lung Cancer Molecular Testing Platform with Boston University and the University of Utah Foundation
6/29/2011 8:50:51 AM
More...
|
|